Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A phase I study of a novel human monoclonal antibody (mAb216) with chemotherapy for the treatment of patients with relapsed or refractory B-lineage acute lymphoblastic leukemia Liedtke, M., Twist, C., Bieber, M., Bhat, N., Teng, N. H., Coutre, S. AMER SOC HEMATOLOGY. 2007: 833A
View details for Web of Science ID 000251100803613